This webpage is intended for UK healthcare professionals. If you are not a healthcare professional, please click here

The UK's

#1

choice

Metoject® is the UK’s most prescribed methotrexate autoinjector, offering the flexibility of 10 dosing options and a ≤5 second injection time1,2

With

0

buttons

Designed with patient-friendly features

Designed to improve the patient experience:

Button-free autoinjector PEN

Acoustic signal at beginning and end of injection

Inspection window to see when injection complete

Hidden needle inside blue needle cover

Larger labelling with colour code

Angular shape with anti-rolling-feature

Patient self-injection guide

Metoject® PEN is a single use device and is injected ONCE a week. Please read the following instructions carefully.

 
Remove the cap.
Do not bend or twist
Position the PEN
Start the injection
Hold the PEN in place to complete the injection
Finishing the injection
Disposing of the PEN

Patient self-injection guide video

Metoject® PEN is a single use device and is injected ONCE a week. Please read the following instructions carefully.

Keep up to date with everything Metoject®!

To get the latest product and service updates about Metoject®, please fill out the form below and subscribe to our mailing list.

* indicates required

Please select all the ways you would like to hear from us:

You can unsubscribe at any time by clicking the link in the footer of our emails. For information about our privacy practices, please visit our website. You will receive emails from marketingteam@medacpharma.co.uk

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

References:

  1. Data on file
  2. Metoject PEN SPC: Available at, https://www.medicines.org.uk/emc/search?q=metoject. Last accessed Sept 2023

Further Information & Questions

REPORTING SIDE EFFECTS

Adverse events should be reported using the forms and information found at yellowcard.mhra.gov.uk

Please also report any adverse events by email to medac drug safety at drugsafety@medac.de

Upon clicking the link below, you will leave metoject.co.uk. Links to all outside websites are provided as a resource to our visitors. medac Pharma accepts no responsibility for the content of other websites.